Aspergillosis is an infection triggered by a collective of molds called Aspergillus. These molds are commonly found in the environment and are typically harmless to healthy individuals. However, in people with weakened immune systems or underlying lung conditions, such as asthma or cystic fibrosis, Aspergillus can cause serious respiratory problems. The infection usually occurs when spores of the mold are inhaled into the lungs, where they can colonize and cause inflammation. Symptoms of aspergillosis can vary depending on the type and severity of the infection but may include coughing, wheezing, chest pain, and shortness of breath. Treatment typically involves antifungal medications to control the infection and may also include measures to address underlying health conditions and boost the immune system.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France